Close menu




May 27th, 2021 | 09:36 CEST

Baidu, The Place Holdings, Tencent - China's economy is booming

  • Investments
Photo credits: pixabay.com

China has achieved what many people long for, a return to normality. Despite the pandemic, the Chinese economy grew 2.3% in 2020, and 8.4% is forecast for this year. The tourism industry could report growth for the first time compared to 2019 due to the increase in domestic travel. In e-commerce, 63% more goods were sold abroad. Despite this, many tech stocks are trading at shallow levels. Today, we look at three stocks from the Middle Kingdom.

time to read: 3 minutes | Author: Armin Schulz
ISIN: US0567521085 , SG1Q02920318 , KYG875721634

Table of contents:


    Baidu - Growing as usual

    Baidu is Asia's search engine with a market share of about 70%. Its main business is online marketing. In addition, a video streaming service has been built up, its operating system has been developed and it has also been involved in autonomous driving. In artificial intelligence (AI), Baidu is very well positioned and is currently growing massively.

    The figures for the first quarter prove this. 70% growth in this division already accounts for more than 20% of Baidu's total revenue.
    Management expects that in 3-5 years the revenue could be higher than that of the core business. The Company plans to grow between 20% and 30% year-on-year in the second quarter. The group also wants to get involved in the semiconductor business and has brought investors on board.

    The stock has fallen to USD 174.05 since its high of USD 354.82 on Feb. 22. Since then, the stock has been trending sideways and is currently at around USD 192. Most recently, the stock tested the 200 moving average several times but was able to establish itself above it. All signs are pointing to growth, and one can build a first position here. If you want a little more security, you can wait for a closing price above USD 198.

    The Place Holdings - Exciting projects with potential

    The Place Holdings has its home on the Singapore stock exchange and focuses on three business areas. The first is the media, advertising and entertainment sector, specifically digital outdoor advertising. Integrated media can be used to breathe new life into underutilized facilities.

    The second mainstay is real estate development. The Company owns two major properties directly in Singapore. Tanjong Pagar was purchased in 2019 and they are now waiting for the change of use to be done as per the Central Business District Incentive Scheme. Once that is complete, they could build a 35-story high-rise there. The second property, Tanah Merah, was only purchased in November 2020. Located on the outskirts of Singapore, it is 8,880sqm and can accommodate up to 265 condominiums and 2,000sqm of commercial space.

    The third business area is cultural tourism. To this end, The Place Holdings acquired an approximately 270,500sqm plot of land near Mount Yuntai, which is a cultural tourist destination. The mountain and surrounding area are listed as a UNESCO Global Geopark. In March, the commercial area became a residential area, which increased the property's value by over 320%.

    Since then, planning has been underway to accommodate both tourism and the New Retail trend. New Retail is the complete integration of online, offline, logistics and technology for a single value chain.

    There is an extraordinary general meeting at which a share reverse split with a factor of 1: 5 is to be decided. That makes sense since there are currently over 5.8 billion shares in circulation; it will likely make the share more tradable. Currently, one should only enter with strict limits.

    Tencent - Penalty still pending

    Tencent is many things - a large technology group, the largest video game provider in the world, a communication platform offering WeChat or QQ with 100s of millions of users, search engines, cashless payment via WeChat Pay or WeBank and is involved in many different large companies such as Tesla, Universal Music, Spotify and Snapchat. Especially in the video games market, the Company has many lucrative investments, such as Riot Games, Activision Blizzard, Supercell and Ubisoft.

    First-quarter numbers were good, with revenue up 25% and profit up 65% year-on-year. The games division increased revenue by 17%. Particularly noteworthy are the two areas, Fintech and Cloud, with a growth of 47%. At the same time, the Company continues to invest heavily in the research and development of tech innovations across all business units.

    The catch for Tencent continues to be the penalty by the Chinese government hanging in the air, and no one knows what it will be. China's political situation is a concern, as the government is bothered by the influence that big tech companies might have on popular opinion. Tencent is currently at around USD 78. One should wait for the penalty before investing in the stock.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read